ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Total Assets history
Currency unavailable · from the balance sheet
No Total Assets data reported for this period type.
Total Assets vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $583.54M USD | +102.4% | +63.4% | |
| Mar 2026 | $443.28M USD | +8.9% | +17.8% | |
| Mar 2026 | $294.73M USD | -10.2% | -1.7% | |
| Mar 2026 | $292.36M USD | — | — | |
| Mar 2026 | $245.41M USD | -26.0% | -15.6% | |
| Mar 2026 | $244.66M USD | +9.2% | -8.4% | |
| Mar 2026 | $187M USD | +77.7% | +155.5% | |
| Mar 2026 | $115.12M USD | -37.9% | +6.9% | |
| Mar 2026 | €99.14M EUR | -39.5% | -13.0% | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| Peer median (excluding ADRX) | — | -0.6% | +2.6% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.